These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19920924)

  • 1. Troglitazone reverses the multiple drug resistance phenotype in cancer cells.
    Davies GF; Juurlink BH; Harkness TA
    Drug Des Devel Ther; 2009 Sep; 3():79-88. PubMed ID: 19920924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Troglitazone overcomes doxorubicin-resistance in resistant K562 leukemia cells.
    Davies GF; Roesler WJ; Juurlink BH; Harkness TA
    Leuk Lymphoma; 2005 Aug; 46(8):1199-206. PubMed ID: 16085563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of peroxisome proliferator-activated receptor agonists on doxorubicin-resistant human myelogenous leukemia (K562/DOX) cells.
    Yousefi B; Samadi N; Baradaran B; Rameshknia V; Shafiei-Irannejad V; Majidinia M; Targhaze N; Zarghami N
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):118-22. PubMed ID: 26718439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balaglitazone reverses P-glycoprotein-mediated multidrug resistance via upregulation of PTEN in a PPARγ-dependent manner in leukemia cells.
    Yousefi B; Azimi A; Majidinia M; Shafiei-Irannejad V; Badalzadeh R; Baradaran B; Zarghami N; Samadi N
    Tumour Biol; 2017 Oct; 39(10):1010428317716501. PubMed ID: 28978268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nelfinavir targets multiple drug resistance mechanisms to increase the efficacy of doxorubicin in MCF-7/Dox breast cancer cells.
    Chakravarty G; Mathur A; Mallade P; Gerlach S; Willis J; Datta A; Srivastav S; Abdel-Mageed AB; Mondal D
    Biochimie; 2016 May; 124():53-64. PubMed ID: 26844637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of tensin homolog deleted on chromosome ten (PTEN) by ciglitazone sensitizes doxorubicin-resistance leukemia cancer cells to treatment.
    Mashayekhi S; Yousefi B; Tohidi E; Darband SG; Mirza-Aghazadeh-Attari M; Sadighparvar S; Kaviani M; Shafiei-Irannejad V; Kafil HS; Karimian A; Jadidi-Niaragh F; Majidinia M
    J Cell Biochem; 2019 Sep; 120(9):15719-15729. PubMed ID: 31087712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells.
    Chauvier D; Morjani H; Manfait M
    Breast Cancer Res Treat; 2002 May; 73(2):113-25. PubMed ID: 12088114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmutinib Reverses Doxorubicin Resistance in ETS1-Overexpressing Leukemia Cells.
    Zhong J; Zhang J; Yu X; Zhang X; Dian L
    Med Sci Monit; 2020 Aug; 26():e924922. PubMed ID: 32830792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells.
    Misra R; Sahoo SK
    Mol Pharm; 2011 Jun; 8(3):852-66. PubMed ID: 21480667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells.
    Huang F; Wu XN; Chen J; Wang WX; Lu ZF
    Exp Ther Med; 2014 Jun; 7(6):1611-1616. PubMed ID: 24926353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
    Zhang ZL; Jiang QC; Wang SR
    Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TFPI1 mediates resistance to doxorubicin in breast cancer cells by inducing a hypoxic-like response.
    Davies GF; Berg A; Postnikoff SD; Wilson HL; Arnason TG; Kusalik A; Harkness TA
    PLoS One; 2014; 9(1):e84611. PubMed ID: 24489651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function and mechanism of pyronaridine: a new inhibitor of P-glycoprotein-mediated multidrug resistance.
    Qi J; Yang CZ; Wang CY; Wang SB; Yang M; Wang JH
    Acta Pharmacol Sin; 2002 Jun; 23(6):544-50. PubMed ID: 12060530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does P-glycoprotein play a pivotal role in the drug resistance of an MDR variant, K562/Dox?
    Hu X; Yang H; Pan QR; Zheng S
    Chemotherapy; 1995; 41(4):296-305. PubMed ID: 7555211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of the expression of multidrug resistance-related genes in human tumour cell lines grown with free doxorubicin or doxorubicin encapsulated in polyisohexylcyanoacrylate nanospheres.
    Laurand A; Laroche-Clary A; Larrue A; Huet S; Soma E; Bonnet J; Robert J
    Anticancer Res; 2004; 24(6):3781-8. PubMed ID: 15736412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pioglitazone, an agonist of PPARγ, reverses doxorubicin-resistance in an osteosarcoma patient-derived orthotopic xenograft model by downregulating P-glycoprotein expression.
    Higuchi T; Sugisawa N; Miyake K; Oshiro H; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Kline Z; Bouvet M; Singh SR; Tsuchiya H; Hoffman RM
    Biomed Pharmacother; 2019 Oct; 118():109356. PubMed ID: 31545293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance in SGC7901/VCR cells by PPARgamma activation by troglitazone.
    Chen Q; Zhou J; Jiang C; Chen J
    J Huazhong Univ Sci Technolog Med Sci; 2010 Jun; 30(3):326-31. PubMed ID: 20556576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of P-glycoprotein-mediated multidrug resistance by guggulsterone in multidrug-resistant human cancer cell lines.
    Xu HB; Xu LZ; Li L; Fu J; Mao XP
    Eur J Pharmacol; 2012 Nov; 694(1-3):39-44. PubMed ID: 22960326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.